Literature DB >> 23526302

Women's experiences with tailored use of a combined oral contraceptive: a qualitative study.

C A Graham1, S Panicker, J Shawe, J Stephenson.   

Abstract

STUDY QUESTION: What are women's experiences with tailored use of combined oral contraceptive pills (COCPs)? SUMMARY ANSWER: Some women reported very positive experiences with tailored use of COCPs, others did not like the unpredictability about when they would bleed and some women reported increased anxiety about possible pregnancy. WHAT IS KNOWN ALREADY: While many studies have investigated views toward extended use of COCPs, little research has examined women's actual experiences with these regimens. STUDY DESIGN, SIZE, DURATION: This was a semi-structured qualitative interview study that was part of a larger randomized trial of a standard (21 daily pills followed by a 7-day pill-free interval) versus a tailored regimen (daily pills until 3-consecutive-day bleeding triggers a 3-day pill-free interval) of Microgynon 30® mcg (Ethinyl estradiol 30 mcg, Levonorgestrel 150 mcg). PARTICIPANTS/MATERIALS, SETTINGS,
METHODS: Interviews were conducted with 26 women (17 in the tailored group and 9 who switched their assigned treatment group) . Data were analyzed using thematic analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Women discussed positive changes associated with tailored use of COCPs, as well as some negative consequences. The major themes identified in the interview data were: ease of tailored regimen; changes in cycle-related symptoms; adjustment to reduced/absent bleeding and unpredictability about bleeding. LIMITATIONS, REASONS FOR CAUTION: The sample comprised mainly young, nulliparous women. The majority of women were using COCPs at the start of the study. WIDER IMPLICATIONS OF THE
FINDINGS: Clinicians discussing extended-use regimes with patients should mention that women may need time to adjust to an extended-use regime. Future research should attempt to identify predictors of response to extended use of COCPs.

Entities:  

Keywords:  combined oral contraceptives; contraception; experience; qualitative study

Mesh:

Substances:

Year:  2013        PMID: 23526302     DOI: 10.1093/humrep/det078

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs.

Authors:  Emily Hoppes; Chukwuemeka Nwachukwu; Julie Hennegan; Diana L Blithe; Amanda Cordova-Gomez; Hilary Critchley; Gustavo F Doncel; Laneta J Dorflinger; Lisa B Haddad; Amelia C L Mackenzie; Jacqueline A Maybin; Kelle Moley; Kavita Nanda; Carolina Sales Vieira; Bellington Vwalika; Simon P S Kibira; Alexandria Mickler; Funmilola M OlaOlorun; Chelsea B Polis; Marni Sommer; Katie M Williams; Eva Lathrop; Tanya Mahajan; Kate H Rademacher; Marsden Solomon; Katrina Wilson; Lucy C Wilson; Lillian Rountree
Journal:  Gates Open Res       Date:  2022-04-19

Review 2.  There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.

Authors:  Chelsea B Polis; Rubina Hussain; Amanda Berry
Journal:  Reprod Health       Date:  2018-06-26       Impact factor: 3.223

3.  Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.

Authors:  Ulrike Sauer; Sue Mann; Nataliya Brima; Judith Stephenson
Journal:  Int J Womens Health       Date:  2013-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.